Cargando…

Repurposing 1,2,4-oxadiazoles as SARS-CoV-2 PLpro inhibitors and investigation of their possible viral entry blockade potential

Although vaccines are obviously mitigating the COVID-19 pandemic diffusion, efficient complementary antiviral agents are urgently needed to combat SARS-CoV-2. The viral papain-like protease (PLpro) is a promising therapeutic target being one of only two essential proteases crucial for viral replicat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ayoup, Mohammed Salah, ElShafey, Mariam M., Abdel-Hamid, Hamida, Ghareeb, Doaa A., Abu-Serie, Marwa M., Heikal, Lamia A., Teleb, Mohamed
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2023
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10008816/ https://www.ncbi.nlm.nih.gov/pubmed/36966652 http://dx.doi.org/10.1016/j.ejmech.2023.115272

Ejemplares similares

Structure optimization of new tumor-selective Passerini α-acyloxy carboxamides as Caspase-3/7 activators
por: Ayoup, Mohammed Salah, et al.
Publicado: (2022)

Reinvestigation of Passerini and Ugi scaffolds as multistep apoptotic inducers via dual modulation of caspase 3/7 and P53-MDM2 signaling for halting breast cancer
por: Ayoup, Mohammed Salah, et al.
Publicado: (2023)

Identification of Doxorubicin as Repurposing Inhibitory Drug for MERS-CoV PLpro
por: Alaofi, Ahmed L., et al.
Publicado: (2022)

1,2,4-Oxadiazole-Bearing Pyrazoles as Metabolically Stable Modulators of Store-Operated Calcium Entry
por: Aprile, Silvio, et al.
Publicado: (2021)

Reactions of 1,2,4‐Oxadiazole[4,5‐a]piridinium Salts with Alcohols: the Synthesis of Alkoxybutadienyl 1,2,4‐Oxadiazoles
por: Moiola, Mattia, et al.
Publicado: (2020)

Novel 1,2,4-Oxadiazole Derivatives in Drug Discovery
por: Biernacki, Karol, et al.
Publicado: (2020)

Room Temperature Synthesis of Bioactive 1,2,4-Oxadiazoles †
por: Baykov, Sergey V., et al.
Publicado: (2023)

Prediction of Motor Recovery after Stroke by Assessment of Corticospinal Tract Wallerian Degeneration Using Diffusion Tensor Imaging
por: Darwish, Hoda Salah, et al.
Publicado: (2021)

Insights Into Drug Repurposing, as Well as Specificity and Compound Properties of Piperidine-Based SARS-CoV-2 PLpro Inhibitors
por: Calleja, Dale J., et al.
Publicado: (2022)

Electrocyclic Ring‐Opening of 1,2,4‐Oxadiazole[4,5‐a]piridinium Chloride: a New Route to 1,2,4‐Oxadiazole Dienamino Compounds
por: Carella, Stefano, et al.
Publicado: (2019)

New 1,2,4-Oxadiazole Nortopsentin Derivatives with Cytotoxic Activity
por: Cascioferro, Stella, et al.
Publicado: (2019)

Inhibitors of SARS-CoV-2 PLpro
por: Calleja, Dale J., et al.
Publicado: (2022)

Research progress on the synthesis and pharmacology of 1,3,4-oxadiazole and 1,2,4-oxadiazole derivatives: a mini review
por: Wang, Jing-Jing, et al.
Publicado: (2022)

Two decades of recent advances of Ugi reactions: synthetic and pharmaceutical applications
por: Fouad, Manar Ahmed, et al.
Publicado: (2020)

4-(N-Phthalimido)phenyl Isonitrile as a Novel Convertible Isocyanide Analogue with the Odorless Property as an Extra Bonus
por: Ayoup, Mohammed Salah, et al.
Publicado: (2023)

Repurposing the antibacterial drugs for inhibition of SARS-CoV2-PLpro using molecular docking, MD simulation and binding energy calculation
por: Patel, Rohit, et al.
Publicado: (2021)

Pitavastatin-loaded bilosomes for oral treatment of hepatocellular carcinoma: a repurposing approach
por: Kharouba, Maged, et al.
Publicado: (2022)

Design, synthesis, and biological activity of novel 1,2,4-oxadiazole derivatives
por: Zhu, Lingzhi, et al.
Publicado: (2020)

Synthesis and Biological Activity of Benzamides Substituted with Pyridine-Linked 1,2,4-Oxadiazole
por: Yang, Sen, et al.
Publicado: (2020)

A review on synthetic account of 1,2,4-oxadiazoles as anti-infective agents
por: Dhameliya, Tejas M., et al.
Publicado: (2022)

Dysregulation of Mycobacterium marinum ESX-5 Secretion by Novel 1,2,4-oxadiazoles
por: Ho, Vien Q. T., et al.
Publicado: (2023)

A Family of Energetic Materials Based on 1,2,4-Oxadiazole and 1,2,5-Oxadiazole Backbones With Low Insensitivity and Good Detonation Performance
por: Xue, Qi, et al.
Publicado: (2020)

SARS-CoV-2: the many pros of targeting PLpro
por: McClain, Christopher B., et al.
Publicado: (2020)

3-(2,4-Dichlorophenyl)-5-methyl-1,2,4-oxadiazole
por: Fun, Hoong-Kun, et al.
Publicado: (2010)

3-(2,4-Dichlorophenyl)-5-phenyl-1,2,4-oxadiazole
por: Fun, Hoong-Kun, et al.
Publicado: (2010)

Novel biphenyl-substituted 1,2,4-oxadiazole ferroelectric liquid crystals: synthesis and characterization
por: Subrao, Mahabaleshwara, et al.
Publicado: (2015)

Synthesis of 5-arylacetylenyl-1,2,4-oxadiazoles and their transformations under superelectrophilic activation conditions
por: Puzanov, Andrey I, et al.
Publicado: (2021)

3D-QSAR Studies of 1,2,4-Oxadiazole Derivatives as Sortase A Inhibitors
por: Shakour, Neda, et al.
Publicado: (2021)

Discovery of 1,2,4-Oxadiazole Derivatives Containing Haloalkyl as Potential Acetylcholine Receptor Nematicides
por: Luo, Ling, et al.
Publicado: (2023)

Major royal jelly proteins elicited suppression of SARS-CoV-2 entry and replication with halting lung injury
por: Abu-Serie, Marwa M., et al.
Publicado: (2023)

Exploration of Nitroaromatic Antibiotics via Sanger’s Reagent: Synthesis, In Silico, and Antimicrobial Evaluation
por: Ayoup, Mohammed Salah, et al.
Publicado: (2022)

Potential anti-proliferative activity of Salix mucronata and Triticum spelta plant extracts on liver and colorectal cancer cell lines
por: Ahmad, Ghada M., et al.
Publicado: (2023)

Author Correction: Potential anti-proliferative activity of Salix mucronata and Triticum spelta plant extracts on liver and colorectal cancer cell lines
por: Ahmad, Ghada M., et al.
Publicado: (2023)

4-[3-(Chloromethyl)-1,2,4-oxadiazol-5-yl]pyridine. Corrigendum
por: Kang, Si-shun, et al.
Publicado: (2008)

3-[3-(Pyridin-3-yl)-1,2,4-oxadiazol-5-yl]propanoic acid
por: Zhang, Fang, et al.
Publicado: (2010)

3-Glucosylated 5-amino-1,2,4-oxadiazoles: synthesis and evaluation as glycogen phosphorylase inhibitors
por: Donnier-Maréchal, Marion, et al.
Publicado: (2015)

Novel 1,2,4-oxadiazole derivatives as selective butyrylcholinesterase inhibitors: Design, synthesis and biological evaluation
por: Nazari, Maryam, et al.
Publicado: (2021)

Development of 1,2,4-Oxadiazole Antimicrobial Agents to Treat Enteric Pathogens within the Gastrointestinal Tract
por: Pitcher, Noel P., et al.
Publicado: (2022)

Boosting the Energetic Performance of Trinitromethyl-1,2,4-oxadiazole Moiety by Increasing Nitrogen-Oxygen in the Bridge
por: Chen, Peng, et al.
Publicado: (2022)

Design, Synthesis, and Biological Activity of Novel Chalcone Derivatives Containing an 1,2,4-Oxadiazole Moiety
por: Luo, Ling, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7of2qto9kjgrsje461r7vkitam